Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Enrico Tendi"'
Publikováno v:
Clinical Drug Investigation. 14:392-399
Some clinical trials have shown that long-term treatment with alpha interferon (IFN) in patients with multiple myeloma can improve survival in comparison with patients not given IFN, but other studies have found no survival benefit in patients treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4aa26d2295755e3752e63b5240db9c4
https://doi.org/10.2165/00044011-199714050-00008
https://doi.org/10.2165/00044011-199714050-00008
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 30(3)
Intravenous immune globulin (IVIg) use for labeled and unlabeled indications has grown in the last years. Aim of this study was to evaluate the IVIg usage profile for neurological inpatients in a single academic medical centre, over a long period of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf2a8d786ebfbaf1efe77488f508534
https://pubmed.ncbi.nlm.nih.gov/19259617
https://pubmed.ncbi.nlm.nih.gov/19259617
Publikováno v:
Oncology Reports.
The main therapeutic options currently available to induce remission in newly diagnosed cases of multiple myeloma include: i) melphalan at conventional doses without concurrent administration of interferon; ii) melphalan at conventional dose combined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4544eabd52a7a6e1b3c8449ded1167
https://doi.org/10.3892/or.5.6.1475
https://doi.org/10.3892/or.5.6.1475
Publikováno v:
European journal of cancer (Oxford, England : 1990). 33(9)
To assess the cost per life year gained of alpha interferon (IFN) as adjuvant therapy for patients with high-risk resected melanoma, we conducted a retrospective, incremental cost-effectiveness analysis on clinical data from a previously published EC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f05c94c112cf9469e2b93aec6565529
https://pubmed.ncbi.nlm.nih.gov/9337671
https://pubmed.ncbi.nlm.nih.gov/9337671
Publikováno v:
Journal of clinical gastroenterology. 23(4)
Recent studies have shown that the analysis of published survival curves allows cost-effectiveness evaluations in which two treatments are compared with each other in terms of cost per life-year saved. In patients with colorectal cancer, the administ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f799a1382b28ccec82cc89f36ec36446
https://pubmed.ncbi.nlm.nih.gov/8957728
https://pubmed.ncbi.nlm.nih.gov/8957728
Publikováno v:
Journal of clinical pharmacy and therapeutics. 21(2)
Standard meta-analytical and pharmacoeconomic techniques were used to study the clinical effectiveness and the cost-effectiveness ratio of the prophylactic (or pre-emptive) administration of G-CSF to patients with small cell lung cancer treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a16818635aa6c37d5a469095270fb8
https://pubmed.ncbi.nlm.nih.gov/8809640
https://pubmed.ncbi.nlm.nih.gov/8809640
Publikováno v:
European journal of clinical pharmacology. 51(2)
The analysis of published survival curves can be used as the basis for incremental cost-effectiveness analyses in which two treatments are compared with each other in terms of cost per life year saved. In patients with node-positive breast cancer adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89adb011dd19c4d68a1b87197ac5725
https://pubmed.ncbi.nlm.nih.gov/8911873
https://pubmed.ncbi.nlm.nih.gov/8911873
Publikováno v:
Journal of Clinical Oncology. 18:3318-3318
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c12cffa0533b97df20e4c052b497a3b3
https://doi.org/10.1200/jco.2000.18.18.3318
https://doi.org/10.1200/jco.2000.18.18.3318
Publikováno v:
Computer Programs in Biomedicine. 18:119-124
A calculator program that performs a nonlinear least-squares fit to data conforming to the one-compartment model with zero-order input is described. The program, which is designed for the Hewlett-Packard HP-41 CV calculator, is based on the Gauss-New
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c2a4e210057fa477ca91974b01c35b
https://doi.org/10.1016/0010-468x(84)90029-1
https://doi.org/10.1016/0010-468x(84)90029-1
Autor:
Stefano Ruffo, Massimo Morfini, Enrico Tendi, Giovanni Longo, Thaddeus H. Grasela, Giancarlo Donati-Cori, Andrea Messori, Marzia Matucci
Publikováno v:
Computer Programs in Biomedicine. 19:167-177
A pharmacokinetic program that allows individualization of drug dosage regimens through the Bayesian method is described. The program, which is designed for the Hewlett-Packard HP-41 CV calculator, is based upon the one-compartment open model with ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d339719ede3ce37549d87993b093a9
https://doi.org/10.1016/0010-468x(85)90008-x
https://doi.org/10.1016/0010-468x(85)90008-x